[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![RedChip Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::25292321.png) RedChip [@RedChip](/creator/twitter/RedChip) on x 5578 followers
Created: 2025-07-15 13:39:20 UTC

🌏 bioAffinity Technologies $BIAF: Patent Granted in China for CyPath® Lung Diagnostic

@bioAffinity has secured a key Chinese patent for its CyPath® Lung test, a noninvasive early detection tool for lung cancer using flow cytometry. The move opens doors in the world’s largest smoking population, with over 300M smokers and 1M+ new lung cancer cases annually.

💡 Why This Matters to Investors:
✅ Expanding Global IP: Strengthens $BIAF's international patent estate across U.S., EU, China, and more.
✅ Market Opportunity: China is a high-need, underdiagnosed market for early-stage lung cancer diagnostics.
✅ Proven Tech: CyPath® Lung delivers XX% sensitivity and XX% accuracy in detecting lung cancer, including Stage X cases.

📄

$BIAF $AZN $KURA $TMO $PHG


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945115969564643425/c:line.svg)

**Related Topics**
[worlds largest](/topic/worlds-largest)
[china](/topic/china)
[$biaf](/topic/$biaf)

[Post Link](https://x.com/RedChip/status/1945115969564643425)